Innovative/Translational Cancer Research Grants

Funding Agency:
Mary Kay Foundation

The Mary Kay Foundation, a funding source for cancer research, is currently accepting applications for innovative grants for translational research for cancers affecting women, including but not limited to ovarian, uterine, breast and/or cervical cancer. Grants will be awarded in the amount of $100,000 over a two-year period.

One grant application will be accepted from each accredited cancer research institute or medical school. It is up to each institute to conduct an internal review process to determine their applicant. No exceptions.



  • Duke Internal: Dec. 4, 2020
  • Sponsor's Application Deadline: February 5, 2021


Agency Website

Eligibility Requirements

The Principal Investigator that completes the applications must be Full-time Assistant Professor or higher at the time of application submission and the same person who signs the electronic signature. Names must match exactly.  Staff scientists, postdoctoral trainees and instructors are NOT eligible.




Amount Description

The grant will be up to $100,000 (combined direct and indirect costs) for a two-year period.  If indirect costs are requested, they cannot exceed 15%.  If selected, the funds will be paid in two payments.  The first payment will be after receipt of the executed contract.  The second payment will be mailed following receipt of the first year status report.  The Foundation anticipates funding between ten and fifteen grants.

Funding Type


Duke Awardees

Victoria Seewaldt, M.D.,
Duke University School of Medicine, associate professor, breast cancer research.
Will investigate genes involved in vitamin A processing to determine if their loss is associated with increased risk for developing breast cancer.

Susan J. Littman, M.D., M.S
The Breast Cancer Susceptibility Gene, BRCA2: Isolation and Study of Its Biological Activity in DNA Repair.


Junior Faculty


Medical - Translational

Internal Nomination

Please submit the following information in one PDF to by Friday  December 4th.

1.      NIH style biosketch for the applicant

2.      2 page description of project

3.    Draft budget and budget justification

Applications will be reviewed by the DCI’s Scientific Review Committee and applicants will be notified of the review outcome no later than December 21st.


Internal Deadline

December 4, 2020

External Deadline

February 5, 2021